6-36855935-T-C

Variant summary

Our verdict is Uncertain significance. The variant received 5 ACMG points: 6P and 1B. PM1PM2PP2PP5BP4

The NM_016059.5(PPIL1):​c.379A>G​(p.Thr127Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000514 in 1,614,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000055 ( 0 hom. )

Consequence

PPIL1
NM_016059.5 missense

Scores

5
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:4U:1

Conservation

PhyloP100: 6.02

Publications

3 publications found
Variant links:
Genes affected
PPIL1 (HGNC:9260): (peptidylprolyl isomerase like 1) This gene is a member of the cyclophilin family of peptidylprolyl isomerases (PPIases). The cyclophilins are a highly conserved, ubiquitous family, members of which play an important role in protein folding, immunosuppression by cyclosporin A, and infection of HIV-1 virions. Based on similarity to other PPIases, this protein could accelerate the folding of proteins and might catalyze the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. [provided by RefSeq, Jul 2008]
PPIL1 Gene-Disease associations (from GenCC):
  • pontocerebellar hypoplasia, type 14
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Broad Center for Mendelian Genomics, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 5 ACMG points.

PM1
In a domain PPIase cyclophilin-type (size 154) in uniprot entity PPIL1_HUMAN there are 7 pathogenic changes around while only 0 benign (100%) in NM_016059.5
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 6 curated pathogenic missense variants (we use a threshold of 10). The gene has 0 curated benign missense variants. Gene score misZ: 0.5799 (below the threshold of 3.09). Trascript score misZ: 0.88366 (below the threshold of 3.09). GenCC associations: The gene is linked to pontocerebellar hypoplasia, type 14.
PP5
Variant 6-36855935-T-C is Pathogenic according to our data. Variant chr6-36855935-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 930026.We mark this variant Likely_pathogenic, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BP4
Computational evidence support a benign effect (MetaRNN=0.17045751). . Strength limited to SUPPORTING due to the PP5.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PPIL1NM_016059.5 linkc.379A>G p.Thr127Ala missense_variant Exon 4 of 4 ENST00000373699.6 NP_057143.1 Q9Y3C6A0A024RCX8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PPIL1ENST00000373699.6 linkc.379A>G p.Thr127Ala missense_variant Exon 4 of 4 1 NM_016059.5 ENSP00000362803.5 Q9Y3C6
PPIL1ENST00000483552.1 linkn.239A>G non_coding_transcript_exon_variant Exon 3 of 3 2

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152068
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000835
AC:
21
AN:
251416
AF XY:
0.0000662
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000150
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000547
AC:
80
AN:
1461892
Hom.:
0
Cov.:
32
AF XY:
0.0000619
AC XY:
45
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.0000671
AC:
3
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000674
AC:
75
AN:
1112012
Other (OTH)
AF:
0.00
AC:
0
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152186
Hom.:
0
Cov.:
32
AF XY:
0.0000403
AC XY:
3
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41532
American (AMR)
AF:
0.0000654
AC:
1
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10592
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
67992
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.542
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000762
Hom.:
0
Bravo
AF:
0.0000264
ExAC
AF:
0.000107
AC:
13
EpiCase
AF:
0.000273
EpiControl
AF:
0.000178

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:4Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Pontocerebellar hypoplasia, type 14 Pathogenic:2
Apr 30, 2021
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Aug 05, 2025
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Low frequency in gnomAD population databases (PM2_sup). Variant is located in a mutational hotspot (PM1_mod). Detected in trans with a pathogenic variant in an affected case (PM3_s). -

Congenital pontocerebellar hypoplasia Pathogenic:1
Jan 20, 2021
Yale Center for Mendelian Genomics, Yale University
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

not provided Pathogenic:1
Dec 11, 2024
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Published functional studies demonstrate a damaging effect of decreased protein level (PMID: 33220177); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 33220177) -

not specified Uncertain:1
May 02, 2019
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant classified as Uncertain Significance - Favor Pathogenic. The p.Thr127Ala variant was identified with a canonical splice variant (phase not determined) in another family with two relatives with a neurodevelopmental phenotype consisting of profound global developmental delays, abnormal muscle tone, and intractable seizures (Gleeson et al, unpublished data). It was also identified in this family in a compound heterozygous state with a loss of function variant in two siblings with profound global developmental delays, microcephaly, intractable seizures, hypotonia, hypoplasia of the corpus callosum, and cortical vision impairment by the Broad Institute Rare Genomes Project. In vitro functional studies of p.Thr127Ala demonstrate a reduction of protein levels in cultured cells (Joseph Gleeson laboratory, UC San Diego, unpublished data) although this observation may not represent disrupted biological function. This variant has been identified in 0.014% of non-Finnish European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org). Computational prediction tools and amino acid conservation analysis suggest that the p.Thr127Ala variant may impact the protein, though this information is not predictive enough to determine pathogenicity through a protein sequence change. Currently, there is moderate evidence to support an association between PPIL1 and a severe neurodevelopmental phenotype. In summary, while there is suspicion for a pathogenic role, the clinical significance of the p.Thr127Ala variant remains uncertain. ACMG/AMP Criteria applied: PS3_Moderate, PM2_Supporting, PP3. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.33
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.042
T
Eigen
Benign
0.039
Eigen_PC
Benign
0.22
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.87
D
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.17
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
2.0
M
PhyloP100
6.0
PrimateAI
Uncertain
0.64
T
PROVEAN
Uncertain
-4.3
D
REVEL
Benign
0.12
Sift
Benign
0.034
D
Sift4G
Benign
0.087
T
Polyphen
0.0010
B
Vest4
0.46
MVP
0.30
MPC
0.35
ClinPred
0.20
T
GERP RS
5.5
Varity_R
0.68
gMVP
0.63
Mutation Taster
=59/41
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs553128312; hg19: chr6-36823711; API